OUR PURPOSE PIONEERING SCIENCE PATIENTS OUR PEOPLE ENVIRONMENT COMMUNITY REPORTING 52 ADVANCING HEALTH ACCESS AND EQUITY BIOGEN 2021 YEAR IN REVIEW In 2021, we also launched a Data Generation DE&I in Medical Research Review Initiative. All 22 studies evaluated met the minimum score, and 20/22 exceeded the minimum score for that criterion. Engagement of key medical experts Our key medical experts (KMEs) provide internal and external guidance, knowledge and support on a variety of health equity topics. They are critical voices with the experience and strategic thinking to help drive solutions that address health inequities. At the 2021 Alzheimer’s Association International Conference (AAIC), our KMEs shared multiple oral and poster presentations from our Alzheimer’s disease clinical development portfolio. Þ READ MORE ABOUT OUR AAIC CONTRIBUTIONS Our UP Working Group is composed of employees with expertise in health equity and/or experience in serving underrepresented and underserved communities, and helped shape and advise on Biogen’s Health Equity policy and initiatives in Alzheimer’s disease. In 2021, UP held four meetings with outputs including the development of the RoAD Show series, a patient perspective video on real-world evidence studies, development of a health equity module as part of ADvance, and the development of a patient/caregiver motivation and expectation survey. We held more than 10 MS Forums with Hispanic MS and medical expert speakers focused on MS cultural competence and shared decision making. Access to our therapies Biogen is dedicated to helping patients obtain access to our therapies. Our skilled patient support representatives have access to a comprehensive suite of financial assistance tools to help patients, their caregivers and healthcare professionals understand, compare and select insurance options and programs that are available to them. We have programs to assist individuals who are uninsured; privately insured; and insured through public programs, such as Medicare. Þ LEARN MORE ABOUT OUR FINANCIAL AND INSURANCE SERVICES Nicole, a rheumatoid arthritis patient in Germany.